›› 2012, Vol. 24 ›› Issue (4): 275-278.doi: 10.3969/j.issn.1004-616x.2012.04.008

• 论著 • 上一篇    下一篇

顺铂对肝癌细胞株SMMC-7721中SATB1表达的影响

禹 莉;凌云志   

  1. ( 1. 蚌埠医学院医学检验系输血学教研室,安徽 蚌埠 233030;2. 蚌埠医学院第一附属医院麻醉科,安徽 蚌埠 233004)
  • 收稿日期:2012-02-27 修回日期:2012-05-16 出版日期:2012-07-30 发布日期:2012-07-30
  • 通讯作者: 禹 莉

Effect of cisplatin on the expression of SATB1 in SMMC-7721 cells

YU Li;LING Yun-zhi   

  1. (1. Department of Transfusion Medicine, Bengbu Medical College, Bengbu 233030; 2. Department of Anesthesiology, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, Anhui, China)
  • Received:2012-02-27 Revised:2012-05-16 Online:2012-07-30 Published:2012-07-30
  • Contact: YU Li

摘要: 目的: 探讨肝癌细胞株SMMC -7721加入顺铂后细胞形态及特异AT序列结合蛋白1 (special AT-rich sequence-binding protein 1,SATB1)表达的变化。方法:SMMC -7721细胞株中加入不同浓度 (0、2. 5、5和10 μg/ml)顺铂培养24 h后,在倒置显微镜下观察细胞形态变化,半定量逆转录RT-PCR法检测SATB1 mRNA的表达,Western blot检测SATB1蛋白的表达。结果:SMMC -7721细胞与不同浓度顺铂共培养24 h后,倒置显微镜下可见细胞形态明显改变,细胞数减少,损伤、死亡的细胞增多。SATB1 mRNA及蛋白的表达均随着顺铂浓度的增加而减少,其中5和10 μg /ml 顺铂组与对照组间的差异均有统计学意义 (P < 0.05或P < 0.01)。结论:顺铂可抑制SMMC-7721细胞增殖及SATB1的表达,从而达到抑制肝癌细胞生长的目的。

关键词: SATB1, SMMC-7721, 顺铂

Abstract: OBJECTIVE: To explore the changes of cell morphology and special AT-rich sequence-binding protein 1 (SATB1) expression after adding different concentrations of cisplatin to SMMC-7721 cells. METHODS: SMMC-7721 cells were treated with 0,2. 5,5 and 10 μg/ml cisplatin for 24 h. The changes of cell morphology were studied through inverted microscope. Semiquantitative reverse transcription polymerase chain reaction (RT-PCR) was used to examine the expression of SATB1 mRNA. Western blot was used to assess the expression of SATB1 protein. RESULTS:When SMMC-7721 cells were cultured with different concentrations of cisplatin for 24 h,significant changes of cell morphology were observed. The cell number decreased. The damaged and dead cells increased. The expressions of SATB1 mRNA and protein were reduced with increasing concentrations of cisplatin. There were statistical significances between 5 and 10 μg /ml cisplatin groups and control group (P<0.05). CONCLUSION:Cisplatin could inhibit the proliferation of SMMC-7721 cell and the expression of SATB1 to suppress the growth of liver cancer cells.

Key words: SATB1, SMMC-7721, cisplatin